MedPath

Comparison of surfactant delivery methods - Endotracheal tube vs Laryngeal mask airway

Phase 4
Conditions
Health Condition 1: P220- Respiratory distress syndrome of newborn
Registration Number
CTRI/2023/07/054608
Lead Sponsor
Srikanth kandi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Preterm neonates with respiratory distress syndrome on CPAP with requirement of FiO2 >0.3 and PEEP of 6cm H2O or more

Exclusion Criteria

Neonates intubated before enrolment

Major congenital malformations

Refusal to participate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success of surfactant delivery: attainment of following parameters within 60 minutes of delivery of Surfactant: <br/ ><br>1. FiO2 0.3 <br/ ><br>2. No / mild retractions <br/ ><br>3. RR: 80 bpm <br/ ><br>Timepoint: 60 minutes after surfactant delivery <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
eed for invasive ventilation during 72 hrs following surfactant delivery <br/ ><br>Number of doses of surfactant required <br/ ><br>Time taken to perform the procedure <br/ ><br>Cumulative duration of respiratory support (non-invasive & invasive ventilation) during hospital stay <br/ ><br>Cumulative duration of following events during & within 10 minutes of the procedure <br/ ><br>a. Apnoea <br/ ><br>b. Preductal oxygen saturations below 85% <br/ ><br>c. Heart rate: bradycardia defined as HR 100 bpm <br/ ><br>Neonatal pain assessment with each procedure: This will be assessed by N-PASS scale <br/ ><br>Proceduralist stress score with each procedure by using Likert scale <br/ ><br>Incidence of IVH, Pneumothorax and BPD <br/ ><br>Amount of gastric leakage of surfactant <br/ ><br>Timepoint: Immediately after surfactant delivery & at discharge of the baby
© Copyright 2025. All Rights Reserved by MedPath